Ernst J, Choteau P
Sem Hop. 1978 Jun;54(17-20):649-52.
The authors of this article, confronted with the frequent and common emergencies associated with the "alcoholic's" behavioral changes-whether he be a symptomatic drinker, an episodic excessive drinker, or a chronic alcoholic-tested an original molecule belonging to the group of alkylsulfone-0-anisamides (triaprid) on twenty patients hospitalized in a general medical service. The results were very encouraging, showing an improvement of numerous symptoms,in patrticular, tremors, diverse pain, and aggressiveness. The authors note that daily doses of 300 to 400 mg of the modification were well tolerated.
本文作者面对与“酗酒者”行为改变相关的常见急症——无论其是有症状的饮酒者、间歇性酗酒者还是慢性酗酒者,在综合内科住院的20名患者身上对一种属于烷基砜-邻-茴香酰胺类(曲阿必利)的原分子进行了测试。结果非常令人鼓舞,显示出许多症状有所改善,尤其是震颤、各种疼痛和攻击性。作者指出,每日300至400毫克的该制剂耐受性良好。